Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
251
NCT00758446
Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 30, 2008
Completion: Jan 31, 2009
NCT01215552
Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712
Phase: Phase 1
Start: Sep 30, 2010
Completion: Jan 31, 2011
NCT01413932
Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder
Phase: Phase 1/2
Start: Jul 31, 2011
Completion: Dec 31, 2012
NCT02013310
HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)
Start: Dec 31, 2013
Completion: Jan 31, 2015
NCT02530307
HT-3951 vs. Placebo in Stroke Rehabilitation
Start: Feb 29, 2016
Completion: Dec 31, 2017
NCT03306329
DNS-7801 vs. Placebo in Parkinson's Disease
Start: Sep 13, 2017
NCT03254160
DNS-3379 vs. Placebo in Stroke Rehabilitation
Start: Nov 13, 2017